Safety and Immunogenicity of SARS-CoV-2 S-2P Protein Vaccine MVC-COV1901 in People Living with HIV
Shu-Hsing Cheng, Chia En Lien, Szu-Min Hsieh, Chien-Yu Cheng, Wang-Da Liu, Ching-Lung Lo, Wen-Chien Ko, Yen-Hsu Chen, Ching-Tai Huang, Hsiao-Ting Chang, Shinn-Jang Hwang, Ning-Chi Wang, Ming-Che Liu, Yu-Lin Lee, I-Chen Tai, View ORCID ProfileJosue Antonio Garcia Estrada, Tzou-Yien Lin, Wen-Sen Lee
doi: https://doi.org/10.1101/2021.12.08.21267439
Shu-Hsing Cheng
aDepartment of Infectious Diseases, Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan, Taiwan
bSchool of Public Health, Taipei Medical University, Taipei, Taiwan
MDChia En Lien
cMedigen Vaccine Biologics, Taipei, Taiwan
dInstitute of Public Health, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan
MDSzu-Min Hsieh
eDepartment of Internal Medicine, Division of Infectious Diseases, National Taiwan University Hospital, Taipei, Taiwan
fCollege of Medicine, National Taiwan University, Taipei, Taiwan
MDChien-Yu Cheng
aDepartment of Infectious Diseases, Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan, Taiwan
gSchool of Public Health, National Yang Ming Chiao Tung University, Taipei, Taiwan
MDWang-Da Liu
eDepartment of Internal Medicine, Division of Infectious Diseases, National Taiwan University Hospital, Taipei, Taiwan
hDepartment of Medicine, National Taiwan University Cancer Center, Taipei, Taiwan
MDChing-Lung Lo
iDepartment of Internal Medicine, National Cheng Kung University Hospital, Tainan, Taiwan
jDepartment of Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan
MDWen-Chien Ko
iDepartment of Internal Medicine, National Cheng Kung University Hospital, Tainan, Taiwan
jDepartment of Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan
MDYen-Hsu Chen
kDepartment of Internal Medicine, Division of Infectious Diseases, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
lSchool of Medicine, Graduate Institute of Medicine, Sepsis Research Centre, Centre of Tropical Medicine and Infectious Diseases, Kaohsiung Medical University, Kaohsiung, Taiwan
MDChing-Tai Huang
mDepartment of Infectious Diseases, Chang Gung Memorial Hospital, Taoyuan, Taiwan
nCollege of Medicine, Chang Gung University, Taoyuan, Taiwan
Hsiao-Ting Chang
oDepartment of Family Medicine, Taipei Veterans General Hospital
pSchool of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan
MDShinn-Jang Hwang
oDepartment of Family Medicine, Taipei Veterans General Hospital
pSchool of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan
MDNing-Chi Wang
qTri-Service General Hospital, Taipei, Taiwan
MDMing-Che Liu
rClinical Research Centre, Taipei Medical University Hospital, Taipei, Taiwan
sSchool of Dental Technology, College of Oral Medicine
MDYu-Lin Lee
tDepartment of Internal Medicine, Changhua Christian Hospital, Changhua, Taiwan
uProgram in Medical Biotechnology, National Chung Hsing University, Taichung, Taiwan
MDI-Chen Tai
cMedigen Vaccine Biologics, Taipei, Taiwan
MDJosue Antonio Garcia Estrada
cMedigen Vaccine Biologics, Taipei, Taiwan
Tzou-Yien Lin
nCollege of Medicine, Chang Gung University, Taoyuan, Taiwan
vDepartment of Paediatrics, Chang Gung Memorial Hospital, Taoyuan, Taiwan
Wen-Sen Lee
wDivision of Infectious Disease, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan
xDepartment of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
MDData Availability
Data sharing is not applicable to this Article, as it is an interim analysis of data from an ongoing study.
Posted December 09, 2021.
Safety and Immunogenicity of SARS-CoV-2 S-2P Protein Vaccine MVC-COV1901 in People Living with HIV
Shu-Hsing Cheng, Chia En Lien, Szu-Min Hsieh, Chien-Yu Cheng, Wang-Da Liu, Ching-Lung Lo, Wen-Chien Ko, Yen-Hsu Chen, Ching-Tai Huang, Hsiao-Ting Chang, Shinn-Jang Hwang, Ning-Chi Wang, Ming-Che Liu, Yu-Lin Lee, I-Chen Tai, Josue Antonio Garcia Estrada, Tzou-Yien Lin, Wen-Sen Lee
medRxiv 2021.12.08.21267439; doi: https://doi.org/10.1101/2021.12.08.21267439
Safety and Immunogenicity of SARS-CoV-2 S-2P Protein Vaccine MVC-COV1901 in People Living with HIV
Shu-Hsing Cheng, Chia En Lien, Szu-Min Hsieh, Chien-Yu Cheng, Wang-Da Liu, Ching-Lung Lo, Wen-Chien Ko, Yen-Hsu Chen, Ching-Tai Huang, Hsiao-Ting Chang, Shinn-Jang Hwang, Ning-Chi Wang, Ming-Che Liu, Yu-Lin Lee, I-Chen Tai, Josue Antonio Garcia Estrada, Tzou-Yien Lin, Wen-Sen Lee
medRxiv 2021.12.08.21267439; doi: https://doi.org/10.1101/2021.12.08.21267439
Subject Area
Subject Areas
- Addiction Medicine (383)
- Allergy and Immunology (699)
- Anesthesia (192)
- Cardiovascular Medicine (2853)
- Dermatology (244)
- Emergency Medicine (430)
- Epidemiology (12562)
- Forensic Medicine (10)
- Gastroenterology (806)
- Genetic and Genomic Medicine (4434)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2850)
- Health Policy (1049)
- Hematology (375)
- HIV/AIDS (893)
- Medical Education (413)
- Medical Ethics (114)
- Nephrology (462)
- Neurology (4195)
- Nursing (222)
- Nutrition (617)
- Oncology (2204)
- Ophthalmology (624)
- Orthopedics (254)
- Otolaryngology (318)
- Pain Medicine (268)
- Palliative Medicine (82)
- Pathology (486)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6783)
- Radiology and Imaging (1490)
- Respiratory Medicine (900)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)